338 related articles for article (PubMed ID: 17596055)
1. Effectiveness of recombinant activated factor VII (rFVII a) for controlling intractable postpartum bleeding: report of two cases and literature review.
Jirapinyo M; Manonai J; Herabutya Y; Chuncharunee S
J Med Assoc Thai; 2007 May; 90(5):977-81. PubMed ID: 17596055
[TBL] [Abstract][Full Text] [Related]
2. The use of recombinant activated factor VII in obstetric and gynaecological haemorrhage.
Franchini M; Lippi G; Franchi M
BJOG; 2007 Jan; 114(1):8-15. PubMed ID: 17233855
[TBL] [Abstract][Full Text] [Related]
3. Use of recombinant activated factor VII in a case of severe postpartum haemorrhage.
Verre M; Bossio F; Mammone A; Piccirillo M; Tancioni F; Varano M
Minerva Ginecol; 2006 Feb; 58(1):81-4. PubMed ID: 16498374
[TBL] [Abstract][Full Text] [Related]
4. A critical review on the use of recombinant factor VIIa in life-threatening obstetric postpartum hemorrhage.
Franchini M; Franchi M; Bergamini V; Salvagno GL; Montagnana M; Lippi G
Semin Thromb Hemost; 2008 Feb; 34(1):104-12. PubMed ID: 18393147
[TBL] [Abstract][Full Text] [Related]
5. Recombinant factor VIIa in the management of postpartum bleeds: an audit of clinical use.
Sobieszczyk S; Breborowicz GH; Platicanov V; Tanchev S; Kessler CM
Acta Obstet Gynecol Scand; 2006; 85(10):1239-47. PubMed ID: 17068684
[TBL] [Abstract][Full Text] [Related]
6. [Post-partum hemorrhage: new therapeutic options].
Franchini M
Recenti Prog Med; 2007 Jan; 98(1):7-11. PubMed ID: 17345873
[TBL] [Abstract][Full Text] [Related]
7. [Recombinant factor VII-a--new possibility for the treatment of severe postpartal bleeding--literature review].
Katsulov A; Getskovski T; Iankov M; Kirova N
Akush Ginekol (Sofiia); 2004; 43(5):44-6. PubMed ID: 15518285
[No Abstract] [Full Text] [Related]
8. Treatment of obstetric hemorrhage with recombinant activated factor VII (rFVIIa).
Segal S; Shemesh IY; Blumenthal R; Yoffe B; Laufer N; Ezra Y; Levy I; Mazor M; Martinowitz U
Arch Gynecol Obstet; 2003 Oct; 268(4):266-7. PubMed ID: 14504866
[TBL] [Abstract][Full Text] [Related]
9. Low-dose recombinant activated factor VII temporally stopped bleeding from small artery in severe postpartum hemorrhage: a case report.
Ogawa M; Akahira S; Takahashi S; Shimoda Y; Sato M; Sato A; Terada Y
Blood Coagul Fibrinolysis; 2013 Apr; 24(3):344-6. PubMed ID: 23448730
[TBL] [Abstract][Full Text] [Related]
10. Recombinant activated factor VII in the treatment of near-fatal bleeding during pediatric brain tumor surgery. Report of two cases and review of the literature.
Hartmann M; Sucker C; Messing M
J Neurosurg; 2006 Jan; 104(1 Suppl):55-8. PubMed ID: 16509483
[TBL] [Abstract][Full Text] [Related]
11. Bleeding and surgery in children with Glanzmann thrombasthenia with and without the use of recombinant factor VII a.
Hennewig U; Laws HJ; Eisert S; Göbel U
Klin Padiatr; 2005; 217(6):365-70. PubMed ID: 16307424
[TBL] [Abstract][Full Text] [Related]
12. Successful treatment with recombinant factor VIIa for intractable bleeding at pelvic surgery.
Daniloś J; Goral A; Paluszkiewicz P; Przesmycki K; Kotarski J
Obstet Gynecol; 2003 Jun; 101(6):1172-3. PubMed ID: 12798520
[TBL] [Abstract][Full Text] [Related]
13. [Using recombinant activated coagulation factor VII (NovoSeven) in obstetrics].
Pekhlivanov B; Milchev N; Abrashev B
Akush Ginekol (Sofiia); 2003; 42(6):7-9. PubMed ID: 15067806
[TBL] [Abstract][Full Text] [Related]
14. Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation.
Pepas LP; Arif-Adib M; Kadir RA
Obstet Gynecol; 2006 Sep; 108(3 Pt 2):757-61. PubMed ID: 17018493
[TBL] [Abstract][Full Text] [Related]
15. The use of recombinant factor VIIa in severe postpartum hemorrhage.
Segal S; Shemesh IY; Blumental R; Yoffe B; Laufer N; Mankuta D; Mazor M; Zohar S; Schiff E; Martinovitz U
Acta Obstet Gynecol Scand; 2004 Aug; 83(8):771-2. PubMed ID: 15255852
[No Abstract] [Full Text] [Related]
16. Using recombinant activated factor VII, B-Lynch compression, and reversible embolization of the uterine arteries for treatment of severe conservatively intractable postpartum hemorrhage: new method for management of massive hemorrhage in cases of placenta increta.
Mechsner S; Baessler K; Brunne B; Albrecht T; Hopp H; Dudenhausen JW
Fertil Steril; 2008 Nov; 90(5):2012.e1-5. PubMed ID: 18462726
[TBL] [Abstract][Full Text] [Related]
17. Use of recombinant factor VIIa for massive postpartum haemhorrage: case series and review of literature.
Shamsi TS; Hossain N; Soomro N; Hasan JA; Noorani M; Kazi S; Quraishy MS; Jameel B; Sultan ST; Haider S
J Pak Med Assoc; 2005 Nov; 55(11):512-5. PubMed ID: 16304877
[TBL] [Abstract][Full Text] [Related]
18. Use of recombinant activated factor VII for massive postpartum hemorrhage.
Hossain N; Shansi T; Haider S; Soomro N; Khan NH; Memon GU; Farzana T; Ansari S; Triche EW; Kuczynski E; Lockwood CJ; Paidas MJ
Acta Obstet Gynecol Scand; 2007 Oct; 86(10):1200-6. PubMed ID: 17851797
[TBL] [Abstract][Full Text] [Related]
19. Caesarean section for placenta praevia complicated by postpartum haemorrhage managed successfully with recombinant activated human coagulation Factor VIIa.
Gidiri M; Noble W; Rafique Z; Patil K; Lindow SW
J Obstet Gynaecol; 2004 Nov; 24(8):925-6. PubMed ID: 16147656
[No Abstract] [Full Text] [Related]
20. Recombinant activated factor VII for intractable bleeding post splenectomy in a patient with myeloproliferative disorder.
El Kinge AR; Mahfouz RA; Shamseddine AI; Taher AT
Blood Coagul Fibrinolysis; 2007 Sep; 18(6):577-9. PubMed ID: 17762536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
